Table 2 Baseline Characteristics of the Patients.
Variable | Control group (n = 41) | TAP + LMA group (n = 42) | P-value |
|---|---|---|---|
Age (years) | 51.4 ± 6.6 | 52.3 ± 6.3 | 0.532 |
Sex (male/female) | 32/9 | 34/8 | 0.791 |
BMI (kg/m2) | 22.3 ± 1.3 | 22.2 ± 1.7 | 0.765 |
ASA physical status (II/III) | 29/12 | 28/14 | 0.690 |
Preoperative Child–Pugh classification of liver function (A/B) | 31/10 | 34/8 | 0.555 |
Number of tumor (1/2) | 28/13 | 33/9 | 0.289 |
Diameter of tumor (mm) | 63.0 ± 17.2 | 64.8 ± 17.4 | 0.648 |
Location of tumor | |||
Left lateral lobe | 8 | 10 | 0.635 |
Left inner lobe | 6 | 7 | 0.799 |
Right anteriorlobe | 18 | 15 | 0.446 |
Right posterior lobe | 9 | 11 | 0.652 |
Clinical stage of tumor (I/II)a | 20/21 | 25/17 | 0.326 |
Cell type of tumor | |||
HCC | 32 | 34 | 0.743 |
ICC | 5 | 3 | 0.436 |
HCC-ICC | 4 | 5 | 0.753 |
Differentiation of tumor | |||
Grade I | 6 | 8 | 0.591 |
Grade II | 26 | 23 | 0.423 |
Grade III | 6 | 9 | 0.421 |
Grade IV | 3 | 2 | 0.625 |
